{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:04:09Z","timestamp":1767920649093,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejso.2022.08.022","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T02:22:09Z","timestamp":1662085329000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-6547","authenticated-orcid":false,"given":"Ekaterina","family":"Baron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-3827","authenticated-orcid":false,"given":"Mary Caitlin","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-5477","authenticated-orcid":false,"given":"Andrei","family":"Nikiforchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-9172","authenticated-orcid":false,"given":"Felipe","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-5278","authenticated-orcid":false,"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-5660","authenticated-orcid":false,"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayotis","family":"Ledakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2022.08.022_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.6363","article-title":"The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery","volume":"156","author":"Kusamura","year":"2021","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.ejso.2022.08.022_bib2","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/cam4.3009","article-title":"Impact of adjuvant chemotherapy on outcomes in appendiceal cancer","volume":"9","author":"Kolla","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.022_bib3","first-page":"3","article-title":"Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"7","author":"Cummins","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2022.08.022_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jss.2019.01.039","article-title":"Who undergoes cytoreductive surgery and perioperative intraperitoneal chemotherapy for appendiceal cancer? An analysis of the national cancer database","volume":"238","author":"Byrne","year":"2019","journal-title":"J\u00a0Surg Res"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.29744","article-title":"The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base","volume":"122","author":"Asare","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.022_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.022_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","article-title":"The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei","volume":"71","author":"Carr","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2022.08.022_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.022_bib9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jso.26371","article-title":"Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience","volume":"123","author":"Nikiforchin","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.022_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.hoc.2012.08.010","article-title":"Neoplasms of the appendix: current treatment guidelines","volume":"26","author":"Shankar","year":"2012","journal-title":"Hematol Oncol Clin N Am"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.022_bib12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jso.25967","article-title":"Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer","volume":"122","author":"Chen","year":"2020","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.08.022_bib13","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1245\/s10434-019-08141-w","article-title":"The safety of iterative cytoreductive surgery and HIPEC for peritoneal carcinomatosis: a high volume center prospectively maintained database analysis","volume":"27","author":"Bekhor","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.022_bib14","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1245\/s10434-021-11233-1","article-title":"Iterative cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous adenocarcinoma of the appendix","volume":"29","author":"Lopez-Ramirez","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2022.08.022_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.2701","article-title":"Adjuvant systemic chemotherapy vs active surveillance following up-front resection of isolated synchronous colorectal peritoneal metastases","volume":"6","author":"Rovers","year":"2020","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.022_bib16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/s10434-015-4914-4","article-title":"Early postoperative chemotherapy after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for isolated peritoneal carcinomatosis of colon cancer: a multicenter study","volume":"23","author":"Maillet","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2022.08.022_bib17","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1158\/1078-0432.CCR-18-3388","article-title":"Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer","volume":"25","author":"Tokunaga","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.022_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jamcollsurg.2011.12.028","article-title":"Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes","volume":"214","author":"Levine","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"issue":"35","key":"10.1016\/j.ejso.2022.08.022_bib19","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","article-title":"Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study","volume":"33","author":"Andr\u00e9","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejso.2022.08.022_bib20","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1200\/JCO.2006.08.2974","article-title":"Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07","volume":"25","author":"Kuebler","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.08.022_bib21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","article-title":"Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer","volume":"29","author":"Haller","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.022_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/s10434-011-1903-0","article-title":"Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer","volume":"19","author":"Halabi","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bjs5.97","article-title":"Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"3","author":"Mercier","year":"2019","journal-title":"BJS Open"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.022_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.canep.2014.04.004","article-title":"Patterns of metachronous metastases after curative treatment of colorectal cancer","volume":"38","author":"van Gestel","year":"2014","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"10.1016\/j.ejso.2022.08.022_bib25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejso.2015.05.018","article-title":"Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: a systematic review","volume":"41","author":"van Oudheusden","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.022_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4251\/wjgo.v2.i1.19","article-title":"Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer","volume":"2","author":"Sugarbaker","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00595-019-01856-z","article-title":"Surgical management for peritoneal carcinomatosis of appendiceal origin with a high-tumor burden","volume":"50","author":"Kitai","year":"2020","journal-title":"Surg Today"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib28","first-page":"251","article-title":"Analysis of treatment failure after complete cytoreductive surgery for peritoneal metastasis from appendiceal mucinous neoplasm at a Japanese high volume center for peritoneal surface malignancy","volume":"46","author":"Yonemura","year":"2019","journal-title":"Gan To Kagaku Ryoho"},{"issue":"5","key":"10.1016\/j.ejso.2022.08.022_bib29","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-012-2238-1","article-title":"Importance of histologic subtype in the staging of appendiceal tumors","volume":"19","author":"Turaga","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1245\/s10434-017-6252-1","article-title":"Validation of the recent PSOGI pathological classification of pseudomyxoma peritonei in a single-center series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"25","author":"Baratti","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1245\/s10434-018-7007-3","article-title":"Outcomes in peritoneal dissemination from signet ring cell carcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"26","author":"Munoz-Zuluaga","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.022_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11605-019-04336-4","article-title":"Should we Be doing cytoreductive surgery with HIPEC for signet ring cell appendiceal adenocarcinoma? A study from the US HIPEC collaborative","volume":"24","author":"Levinsky","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.022_bib33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdr279","article-title":"Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix","volume":"23","author":"Lieu","year":"2012","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2022.08.022_bib34","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1245\/s10434-009-0536-z","article-title":"Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma","volume":"16","author":"Chua","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2022.08.022_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13193-018-00870-w","article-title":"Analysis of clinical outcomes of pseudomyxoma peritonei from appendicular origin following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-A retrospective study from INDEPSO","volume":"10","author":"Sinukumar","year":"2019","journal-title":"Indian J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.022_bib36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1245\/s10434-014-4147-y","article-title":"Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases","volume":"22","author":"Votanopoulos","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2022.08.022_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23547","article-title":"Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"109","author":"Blackham","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.08.022_bib38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ejso.2019.05.008","article-title":"Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin","volume":"45","author":"Munoz-Zuluaga","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.022_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jso.21679","article-title":"Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin","volume":"102","author":"Sugarbaker","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.022_bib40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.24715","article-title":"Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience","volume":"116","author":"Shapiro","year":"2010","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2022.08.022_bib41","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1245\/s10434-020-09330-8","article-title":"Clinical and radiologic predictors of a pathologic complete response to neoadjuvant chemotherapy (NACT) in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: results of a prospective multi-center study","volume":"28","author":"Bhatt","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.022_bib42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ejca.2010.01.020","article-title":"Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis","volume":"46","author":"Des Guetz","year":"2010","journal-title":"Eur J Cancer"},{"issue":"22","key":"10.1016\/j.ejso.2022.08.022_bib43","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.2011.749","article-title":"Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis","volume":"305","author":"Biagi","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ejso.2022.08.022_bib44","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2022.08.022_bib45","article-title":"Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases","volume":"5","author":"Loupakis","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.08.022_bib46","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1245\/s10434-020-08331-x","article-title":"Prognostic utility of pre- and postoperative circulating tumor DNA liquid biopsies in patients with peritoneal metastases","volume":"27","author":"Baumgartner","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"4_suppl","key":"10.1016\/j.ejso.2022.08.022_bib47","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.4_suppl.029","article-title":"Correlation of circulating tumor DNA (ctDNA) with clinical outcomes in appendiceal cancers (AC)","volume":"40","author":"Kothary","year":"2022","journal-title":"J\u00a0Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:46:23Z","timestamp":1760060783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322006291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0748798322006291"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.022","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}